Biocon gets VAI status for Andhra Pradesh’s API facility

29 Jan 2026 Evaluate

Biocon has received a Voluntary Action Indicated (VAI) status from the U.S. Food and Drug Administration (USFDA) for its API facility located in Andhra Pradesh. This is based on an inspection conducted by the agency between November 3, 2025 and November 07, 2025.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

363.10 -7.05 (-1.90%)
29-Jan-2026 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.00
Dr. Reddys Lab 1208.55
Cipla 1318.50
Zydus Lifesciences 892.00
Lupin 2122.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×